AzTrials
AzTrials

Mental IllnessCORALNCT01379014

CORAL Study: Proof of Concept Trial

A study testing Decision Aid Tool and Treatment as Usual in people with Mental Illness, run by Institute of Psychiatry, London at 1 site in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

A decision aid tool (DAT) to assist mental health service users in reaching disclosure decisions in the context of employment was developed in a previous study (IRAS REC ref: 07/Q0706/21). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Mental Illness
What is being tested?
Decision Aid Tool and Treatment as Usual
Could I receive a placebo?
No, everyone receives an active treatment
How many people
84 participants
Where
1 siteUnited Kingdom
Study dates
Jul 2011to Mar 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • On the caseload of a vocational specialist working with people with mental illness.
  • Referred to the adviser either from an Increased Access to Psychological Therapies or secondary mental health care service.
  • Aged 18 years or older
  • Currently seeking either paid or voluntary employment or interested in seeking paid or voluntary employment
  • Decisional conflict scale score of 37.5 or greater and stage of decision score 1-5

Who cannot join

  • Insufficient English to use the decision aid tool
  • Lack of capacity to provide informed consent

Trial locations and contacts

1 site in 1 country.

Claire Henderson, MRCPsych contact

02078485075

claire.1.henderson@kcl.ac.uk

United Kingdom1 site, 1 recruiting
  • Institute of Psychiatry, King's College London

    London, SE5 8AF

    Recruiting

Other trials in United Kingdom

About this study

Official title: The CORAL Study of a Decision Aid Tool Regarding Disclosure of Mental Health Status to an Employer: Proof of Concept Randomised Control Trial

A decision aid tool (DAT) to assist mental health service users in reaching disclosure decisions in the context of employment was developed in a previous study (IRAS REC ref: 07/Q0706/21). The initial feasibility and acceptability was assessed in a group of 15 mental health service users with mean decisional conflict scores reduced from 51.98 to 35.52 after completion. 60% of participants reported that the DAT was quick to complete, 40% that it was easy, 60% that it was relevant and 80% that they would definitely or probably use it in making disclosure decisions. This current study (CORAL: Proof of concept RCT) aims to determine whether a full randomised controlled trial of the DAT is justifiable and feasible, and to optimise its design. This will consider: 1) effects of the intervention; 2) baseline predictors of disclosure; and 3) exploration of the relationship between use of the DAT and the rate of disclosure.

Eighty people who are on the caseload of a vocational specialist working with people with mental illness will be included in this study. All participants will be receiving treatment from an Improving Access to Psychological Therapies (IAPT) service or a Community Mental Health Team (CMHT). An equal number from each group will be allocated to receive either the DAT intervention or treatment as usual. Individuals from both groups will complete baseline assessment and 3month followup assessments. Those allocated to the intervention will also complete an assessment immediately following the intervention. Qualitative interviews will also be conducted at 3 months with a maximum of 15 people from the intervention group and 6 people from the control group.

Read the detailed description

The principal aims are to determine whether a full randomised controlled trial of the CORAL decision aid tool is justifiable and feasible and to optimise its design. Specific objectives are as follows:

  1. To examine the effect of the DAT on decisional conflict regarding disclosure both immediately and at 3 months post first use.
  2. To collect data to inform sample size calculations for the primary outcome measures for use in a future full scale trial(gaining employment and workplace accommodations).
  3. To test study procedures, including the sample that can be drawn using the inclusion and exclusion criteria; the full time equivalent needed for research assistants to recruit sufficient numbers and carry out the study procedures in the time available; and whether the measure leads to too much respondent burden.
  4. To pilot the use of a questionnaire on employment and disclosure related activities.
  5. To test the selected randomisation method, in this case individual level randomisation, including the methods for avoiding and measuring contamination.
  6. To pilot recruitment and retention methods for service users and vocational specialists.
  7. To estimate effect sizes and their confidence intervals for employment related activities (proxy outcome measures for gaining employment and workplace accommodations), in order to determine whether a full scale trial is justified.
  8. To modify the conceptual model
Conditions
Mental Illness
Being tested
Decision Aid Tool, Treatment as Usual
Keywords
Decisional conflict, Disclosure, Mental Health history, Mental health service users, Decision Aid Tool, Vocational Specialists
Medical subject headings
Mental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Decision Aid ToolBehavioural

    A booklet which outlines to pros and cons of different decision outcomes, and is designed to assist the user in making a decision according to their own specific circumstances

  • Treatment as UsualOther

    The control group does not receive a copy of the decision aid tool booklet, instead received treatment as usual from vocational specialist

Study groups in NCT01379014
Study groupRoleWhat they receive
Decision Aid ToolExperimentalIntervention group - receives the decision aid tool in booklet form and is introduced to it by an investigator.
Receives: Behavioral: Decision Aid Tool
ControlNo interventionThe control group does not receive a copy of the decision aid tool booklet, instead received treatment as usual from vocational specialist
Receives: Other: Treatment as Usual

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. decisional conflict scale

    Decisional conflict scale (O'Connor, 1993) This measures personal perceptions of uncertainty, lack of clarity and effectiveness in decision making. Has 16 items with each rated on a 5 point Likert scale ranging from 0=strongly agree to 4=strongly disagree.

    Measured: Change from baseline in decisional conflict at 3 months

Secondary outcomes (11)
  1. Sociodemographic data

    Socio-demographic and clinical data to be collected as part of the baseline interview will include age, gender, years since first contact with mental health services, education, employment status and history, housing arrangements, source of income, current mental health care, knowledge of clinical diagnosis, agreement with diagnosis and information on social networks.

    Measured: baseline

  2. Employment related questions

    To record how many jobs applications, apppointments with vocational specialists, training days and job applications the participant has completed in the preceeding 3 months.

    Measured: baseline and 3-month follow up

  3. Discrimination and Stigma Scale (DISC)

    scale to assess mental health service users' experiences of discrimination. 22 items. Baseline assesses if discrimination/stigma has ever been experienced, 3 month follow-up asks if discrimination/stigma as been experienced in the past three months.

    Thornicroft, G., Brohan, E., Rose, D., Sartorius, N. \& the INDIGO study group. (2009) Global pattern of experienced and anticipated discrimination against people with schizophrenia. The Lancet, 373 (9661), 408-415

    Measured: Baseline and 3-month follow-up

  4. Questionnaire on Anticipated Discrimination (QUAD)

    The QUAD is a self-complete measure which contains 17 items which address 'areas of anticipated discrimination'. This asks participants to provide a rating of whether they expect to be treated unfairly in various areas of life. Each item is scored on a five point Likert scale ranging from 0 (Strongly disagree) to 4 (Strongly agree).

    Brohan E, Clement S, Thornicroft G. Development and initial validation of the questionnaire on anticipated discrimination (QUAD v6, May 2011) © 2011, Institute of Psychiatry, King's College London

    Measured: baseline and 3 month follow-up

  5. Boston University Empowerment Scale (BUES)

    This 28-item scale was developed with an emphasis on service user-involvement at all stages of design and testing. This version has shown adequate internal consistency (α=.86).

    Rogers, E. S., Chamberlin, J., Ellison, M. L., et al (1997) A consumer-constructed scale to measure empowerment among users of mental health services. Psychiatric Services, 48, 1042-1047.

    Measured: baseline and 3 month follow-up

  6. Internalised Stigma of Mental Illness Scale (ISMI)

    The ISMI is a 29-item measure that assesses mental health service users' experience of internalised stigma. It is composed of 5 sub-scales: Alienation, Stereotype Endorsement, Perceived Discrimination, Social Withdrawal and Stigma Resistance. Strong internal consistency (α = 0.90) and test-retest reliability(r=0.92) have been reported Ritsher JB, Otilingam PG, Grajales M. Internalized stigma of mental illness: Psychometric properties of a new measure. Psychiatry Research 2003;121(1):31-49.

    Measured: Baseline and 3 month follow-up

  7. Perceived Devaluation and Discrimination Scale (PDD)

    The PDD is a 12-item, uni-dimensional, scale which measures the extent to which a person believes that people will devalue or discriminate against those with a mental illness. This scale has been widely used and has excellent psychometric properties

    Link, B.G., Neese-Todd, S., Asmussen, S. \& Phelan, J.C. (2002). On describing and seeking to change the experience of stigma. Psychiatric Rehabilitation Skills, 6: 201-231.

    Measured: Baseline and 3 month follow-up

  8. Stigma Coping Orientation Scales

    Measures to assess approaches to coping with the stigma associated with mental illness. Revised versions of four of the scales are now available and will be used in this study. These are secrecy (5-items alpha = .85), withdrawal (5-items alpha = .71), challenging (5 items alpha = .75) and distancing (3 items alpha = .62) (Bruce Link, personal communication).

    The Effectiveness of Stigma Coping Orientations: Can Negative Consequences of Mental Illness Labeling be Avoided? Bruce G. Link, Jerrold Mirotznik, Francis T. Cullen, Journal of Health and Social Behavior, Vol. 32, No. 3 (Sep., 1991)

    Measured: baseline and 3 month follow-up

  9. Brief COPE

    A short-version COPE Inventory. Assesses response to stress. 14 scales with two items each; self-distraction, active coping, denial, substance use, use of emotional support, use of instrumental support, behavioral disengagement, venting, positive reframing, planning, humor, acceptance, religion and self-blame. Reliability analyses exceeded alpha=0.60, except for venting, denial and acceptance, all of which exceed alpha = 0.50 (Carver et al 1997)

    Carver, C. S. (1997). International Journal of Behavioral Medicine, 4, 92-100

    Measured: Baseline and 3-months Follow-up

  10. Work Limitations Questionnaire (WLQ)

    The 8-item short WLQ measures the degree to which employed individuals are experiencing limitations on-the-job due to their health problems, and health-related productivity loss.

    Work Limitations Questionnaire, 1998. The Health Institute, Tufts Medical Center, 800 Washington Street, Nemc #345, Boston, MA 02111

    Measured: Baseline and 3 month follow-up (for those in employment only)

  11. stage of decision making scale

    Stage of decision making scale (O'Connor, 2000).This measures the individual's readiness to engage in decision making It consists of 1 item with 6 response options anchored at 1 (haven't started to think about the choices) and 6 (have already made a decision and am unlikely to change my mind).

    Measured: Baseline and 3 month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jun 2011 (estimated)
  2. Study startJul 2011
  3. Primary completionMar 2013 (estimated)
  4. Study completionMar 2013 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
84 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01379014
Sponsor's protocol ID
11/EE/0156
Acronym
CORAL
Status last verified
Nov 2011
First submitted
17 Jun 2011
Last updated
2 Nov 2011
Results posted
No
Data monitoring committee
No

Publications

  • Henderson C, Brohan E, Clement S, Williams P, Lassman F, Schauman O, Dockery L, Farrelly S, Murray J, Murphy C, Slade M, Thornicroft G. Decision aid on disclosure of mental health status to an employer: feasibility and outcomes of a randomised controlled trial. Br J Psychiatry. 2013 Nov;203(5):350-7. doi: 10.1192/bjp.bp.113.128470. Epub 2013 Sep 26.

    PubMed 24072755
  • Henderson C, Brohan E, Clement S, Williams P, Lassman F, Schauman O, Murray J, Murphy C, Slade M, Thornicroft G. A decision aid to assist decisions on disclosure of mental health status to an employer: protocol for the CORAL exploratory randomised controlled trial. BMC Psychiatry. 2012 Aug 31;12:133. doi: 10.1186/1471-244X-12-133.

    PubMed 22938019

Questions about this trial

What is this clinical trial studying?

A study testing Decision Aid Tool and Treatment as Usual in people with Mental Illness, run by Institute of Psychiatry, London at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Nov 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Claire Henderson, MRCPsych (02078485075, claire.1.henderson@kcl.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

decisional conflict scale (time frame: Change from baseline in decisional conflict at 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01379014, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2011.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in